Researchers at a BSL-3 lab tied to the organizers of the 2001 Dark Winter simulation, DARPA, and the post-9/11 biodefense industrial complex are genetically modifying anthrax to express Covid-19 components, according to FOIA documents.
Michael Callahan’s career began in USAID and USSR bioweapons labs, where he advanced the agenda of the bioweapons and pharmaceutical cartels. From there, he massively expanded DARPA’s biodefense portfolio and today finds himself squarely in the center of the origins of the coronavirus pandemic.
A 2019 document from a US government AI commission, led by former Google CEO Eric Schmidt, says the US must copy and beat China’s mass surveillance by removing “legacy systems” like cash, car ownership and in-person doctors. Under cover of COVID-19, that wishlist is coming true.
One of the most politically-connected yet scandal ridden vaccine companies in the United States, with troubling ties to the 2001 anthrax attacks and opioid crisis, is set to profit handsomely from the current Coronavirus crisis.
The leaders of Event 201 and Crimson Contagion, both held months before COVID-19, share a past in Dark Winter, the June 2001 exercise that foreshadowed the anthrax attacks. This article revisits those attacks, the ensuing cover-up and how key players in those affairs now run the COVID response.
